Evaluation of 30-day mortality of levosimendan versus enoximone.
Rijnders
Bart J A
BJ
D002316:Cardiotonic Agents / Q000627:therapeutic use*; D017335:Enoximone / Q000627:therapeutic use*; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D011724:Pyridazines / Q000627:therapeutic use*; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000401:mortality*; D000077464:Simendan; D013997:Time Factors
D002316:Cardiotonic Agents; D006835:Hydrazones; D010726:Phosphodiesterase Inhibitors; D011724:Pyridazines; D000077464:Simendan; D017335:Enoximone